CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,220 | -59.9% | 83,430 | -42.4% | 0.00% | – |
| Q3 2022 | $23,000 | -34.3% | 144,840 | +8.2% | 0.00% | – |
| Q2 2022 | $35,000 | -45.3% | 133,836 | +11.2% | 0.00% | – |
| Q1 2022 | $64,000 | -95.0% | 120,325 | -94.2% | 0.00% | – |
| Q4 2021 | $1,282,000 | -52.9% | 2,082,036 | -22.0% | 0.00% | – |
| Q3 2021 | $2,723,000 | -42.6% | 2,669,794 | +3.0% | 0.00% | -100.0% |
| Q2 2021 | $4,743,000 | -39.2% | 2,592,114 | -34.6% | 0.00% | 0.0% |
| Q1 2021 | $7,804,000 | +731.1% | 3,961,808 | +427.5% | 0.00% | – |
| Q4 2020 | $939,000 | -29.0% | 751,086 | +2.3% | 0.00% | – |
| Q3 2020 | $1,322,000 | -88.3% | 734,526 | -45.4% | 0.00% | -100.0% |
| Q2 2020 | $11,289,000 | +178.3% | 1,345,478 | +73.8% | 0.00% | +100.0% |
| Q1 2020 | $4,056,000 | -5.5% | 774,023 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $4,291,000 | -2.6% | 785,938 | -13.1% | 0.00% | 0.0% |
| Q3 2019 | $4,405,000 | -31.7% | 904,587 | -2.9% | 0.00% | -50.0% |
| Q2 2019 | $6,454,000 | -1.5% | 931,308 | -1.2% | 0.00% | 0.0% |
| Q1 2019 | $6,550,000 | +24.4% | 942,508 | +4.6% | 0.00% | 0.0% |
| Q4 2018 | $5,264,000 | -20.9% | 901,426 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $6,659,000 | +86.7% | 882,068 | +24.9% | 0.00% | +100.0% |
| Q2 2018 | $3,566,000 | -5.8% | 706,363 | +13.9% | 0.00% | 0.0% |
| Q1 2018 | $3,784,000 | -4.8% | 620,369 | +10.8% | 0.00% | 0.0% |
| Q4 2017 | $3,976,000 | +475.4% | 559,895 | +480.0% | 0.00% | – |
| Q3 2017 | $691,000 | +0.7% | 96,530 | -11.4% | 0.00% | – |
| Q2 2017 | $686,000 | -47.3% | 108,978 | -30.9% | 0.00% | – |
| Q1 2017 | $1,302,000 | +39.4% | 157,734 | +43.0% | 0.00% | – |
| Q4 2016 | $934,000 | +360.1% | 110,328 | +268.9% | 0.00% | – |
| Q3 2016 | $203,000 | +153.8% | 29,909 | +12.4% | 0.00% | – |
| Q2 2016 | $80,000 | +700.0% | 26,609 | +401.2% | 0.00% | – |
| Q1 2016 | $10,000 | 0.0% | 5,309 | -15.9% | 0.00% | – |
| Q4 2015 | $10,000 | -41.2% | 6,309 | -39.9% | 0.00% | – |
| Q3 2015 | $17,000 | +6.2% | 10,500 | +96.1% | 0.00% | – |
| Q2 2015 | $16,000 | – | 5,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |